[English] 日本語

- EMDB-51513: PbuCas13b Helical-2 domain in complex with anti-CRISPR protein (A... -
+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | PbuCas13b Helical-2 domain in complex with anti-CRISPR protein (AcrVIB1) | |||||||||
![]() | ||||||||||
![]() |
| |||||||||
![]() | AcrVIB1 / anti-CRISPR protein / Cas13b / RNA BINDING PROTEIN | |||||||||
Biological species | ![]() ![]() | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 5.11 Å | |||||||||
![]() | Schmelz S / Lukat P / Blankenfeldt W | |||||||||
Funding support | 1 items
| |||||||||
![]() | ![]() Title: AcrVIB1 inhibits CRISPR-Cas13b immunity by promoting unproductive crRNA binding accessible to RNase attack. Authors: Katharina G Wandera / Stefan Schmelz / Angela Migur / Anuja Kibe / Peer Lukat / Tatjana Achmedov / Neva Caliskan / Wulf Blankenfeldt / Chase L Beisel / ![]() Abstract: Anti-CRISPR proteins (Acrs) inhibit CRISPR-Cas immune defenses, with almost all known Acrs acting on the Cas nuclease-CRISPR (cr)RNA ribonucleoprotein (RNP) complex. Here, we show that AcrVIB1 from ...Anti-CRISPR proteins (Acrs) inhibit CRISPR-Cas immune defenses, with almost all known Acrs acting on the Cas nuclease-CRISPR (cr)RNA ribonucleoprotein (RNP) complex. Here, we show that AcrVIB1 from Riemerella anatipestifer, the only known Acr against Cas13b, principally acts upstream of RNP complex formation by promoting unproductive crRNA binding followed by crRNA degradation. AcrVIB1 tightly binds to Cas13b but not to the Cas13b-crRNA complex, resulting in enhanced rather than blocked crRNA binding. However, the more tightly bound crRNA does not undergo processing and fails to activate collateral RNA cleavage even with target RNA. The bound crRNA is also accessible to RNases, leading to crRNA turnover in vivo even in the presence of Cas13b. Finally, cryoelectron microscopy (cryo-EM) structures reveal that AcrVIB1 binds a helical domain of Cas13b responsible for securing the crRNA, keeping the domain untethered. These findings reveal an Acr that converts an effector nuclease into a crRNA sink to suppress CRISPR-Cas defense. | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 12 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 18.3 KB 18.3 KB | Display Display | ![]() |
Images | ![]() | 106.9 KB | ||
Filedesc metadata | ![]() | 5.5 KB | ||
Others | ![]() ![]() | 12 MB 12 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
-
Links
EMDB pages | ![]() ![]() |
---|
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.91 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Half map: #1
File | emd_51513_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: #2
File | emd_51513_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : PbuCas13b Helical-2 domain in complex with AcrVIB1
Entire | Name: PbuCas13b Helical-2 domain in complex with AcrVIB1 |
---|---|
Components |
|
-Supramolecule #1: PbuCas13b Helical-2 domain in complex with AcrVIB1
Supramolecule | Name: PbuCas13b Helical-2 domain in complex with AcrVIB1 / type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
---|---|
Source (natural) | Organism: ![]() |
-Macromolecule #1: PbuCas13b Helical-2 domain
Macromolecule | Name: PbuCas13b Helical-2 domain / type: protein_or_peptide / ID: 1 / Details: PbuCas13b Helical-2 domain (residues 579 - 747) / Enantiomer: DEXTRO |
---|---|
Source (natural) | Organism: ![]() |
Recombinant expression | Organism: ![]() ![]() |
Sequence | String: GGGRRCKDMG KEAE RKIGE MIDDTQRRLD LLCKQTNQKI RIGKRNAGLL KSGKI ADWL VNDMMRFQPV QKDQNNIPIN NSKANSTEYR MLQRAL ALF GSENFRLKAY FNQMNLVGND NPHPFLAETQ WEHQTNI LS FYRNYLEARK KYLKGLKPQN WKQYQHFLIL KVQKCNR |
-Macromolecule #2: AcrVIB1
Macromolecule | Name: AcrVIB1 / type: protein_or_peptide / ID: 2 / Enantiomer: DEXTRO |
---|---|
Source (natural) | Organism: ![]() |
Recombinant expression | Organism: ![]() ![]() |
Sequence | String: GGGRMKDLDL SKLKGEEIAQ WLLNNKKA T AIQLSSERTD TDDGFMHILV HKDEYVEIIY SYLKIDEDD VMQNFTIYSK RWGNIDNSYF ELQTFEGEIF TGESDKILCG VLSLGDLTT LK |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Concentration | 0.1 mg/mL |
---|---|
Buffer | pH: 7 / Details: 20mM HEPES pH7.5 150 mM NaCl |
Grid | Model: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 200 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 100 sec. / Pretreatment - Atmosphere: AIR / Pretreatment - Pressure: 4.0 kPa |
Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 283 K / Instrument: FEI VITROBOT MARK IV |
Details | The SEC co-purified complex of PbuCas13b_ Helical-2:AcrVIB1 was diluted to 0.1 mg/ml and used for grid preparation |
-
Electron microscopy
Microscope | TFS GLACIOS |
---|---|
Specialist optics | Energy filter - Name: TFS Selectris / Energy filter - Slit width: 10 eV |
Software | Name: EPU (ver. 3.3.1.5184) |
Image recording | Film or detector model: TFS FALCON 4i (4k x 4k) / Number real images: 10707 / Average electron dose: 60.0 e/Å2 |
Electron beam | Acceleration voltage: 200 kV / Electron source: ![]() |
Electron optics | C2 aperture diameter: 50.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 1.6 µm / Nominal defocus min: 0.6 µm |
Sample stage | Cooling holder cryogen: NITROGEN |
-
Image processing
Startup model | Type of model: INSILICO MODEL / Details: insilco model generated with cryoSPARC in C1 |
---|---|
Final reconstruction | Applied symmetry - Point group: C1 (asymmetric) / Resolution.type: BY AUTHOR / Resolution: 5.11 Å / Resolution method: FSC 0.143 CUT-OFF / Software - Name: cryoSPARC (ver. v4.5.3) / Number images used: 1078020 |
Initial angle assignment | Type: MAXIMUM LIKELIHOOD / Software - Name: cryoSPARC (ver. v4.5.3) |
Final angle assignment | Type: MAXIMUM LIKELIHOOD / Software - Name: cryoSPARC (ver. v4.5.3) |